Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-04-08 Sale |
2024-04-08 9:34 pm |
Societal CDMO Inc. | SCTL | Reasons Bryan M. Director |
73,620 | $1.1 | $80,982 | 0 (Direct) |
View |
2023-11-14 Sale |
2023-11-16 4:15 pm |
Mallinckrodt plc | MNKTQ | Reasons Bryan M. EVP & CFO |
96,660 | $0 | $0 | 0 (Direct) |
View |
2023-08-28 Purchase |
2023-08-28 4:32 pm |
Societal CDMO Inc. | SCTL | Reasons Bryan M. Director |
62,500 | $0.4 | $25,000 | 291,049 (Direct) |
View |
2022-06-16 Sale |
2022-06-21 6:23 pm |
Mallinckrodt plc | MNKPF | Reasons Bryan M. EVP & CFO |
11,593 | $0 | $0 | 0 (Direct) |
View |
2020-12-03 Sale |
2020-12-07 4:13 pm |
Mallinckrodt plc | MNKKQ | Reasons Bryan M. EVP & CFO |
5,400 | $0.165 | $891 | 11,593 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-01 Exercise |
2025-01-02 5:01 pm |
N/A N/A |
Mallinckrodt plc | Reasons Bryan M. EVP & CFO |
6,838 | $0 | 18,793 (Direct) |
View | |
2025-01-01 Tax Withholding |
2025-01-02 5:01 pm |
N/A N/A |
Mallinckrodt plc | Reasons Bryan M. EVP & CFO |
1,724 | $0 | 18,793 (Direct) |
View | |
2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
4,660 | $0 | 28,732 (Direct) |
View |
2024-04-08 Equity Swap |
2024-04-08 9:34 pm |
N/A N/A |
Societal CDMO Inc. | SCTL | Reasons Bryan M. Director |
217,429 | $1.1 | 0 (Direct) |
View |
2024-02-02 Option Award |
2024-02-06 4:31 pm |
N/A N/A |
Mallinckrodt plc | Reasons Bryan M. EVP & CFO |
20,517 | $0 | 20,517 (Direct) |
View | |
2023-08-17 Tax Withholding |
2023-08-18 9:21 pm |
N/A N/A |
Mallinckrodt plc | MNK | Reasons Bryan M. EVP & CFO |
15,976 | $0.693 | 96,660 (Direct) |
View |
2023-06-02 Exercise |
2023-06-05 4:57 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
4,507 | $0 | 44,482 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:57 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
20,410 | $0 | 44,482 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:55 pm |
N/A 2033-05-17 |
Societal CDMO Inc. | SCTL | Reasons Bryan M. Director |
100,849 | $0 | 255,778 (Direct) |
View |
2023-04-03 Option Award |
2023-04-05 7:06 pm |
N/A N/A |
Mallinckrodt plc | MNK | Reasons Bryan M. EVP & CFO |
168,237 | $0 | 168,237 (Direct) |
View |
2022-12-14 Option Award |
2022-12-22 5:47 pm |
N/A N/A |
Mallinckrodt plc | MNK | Reasons Bryan M. EVP & CFO |
112,636 | $0 | 112,636 (Direct) |
View |
2022-06-03 Exercise |
2022-06-06 5:33 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
3,356 | $0 | 39,822 (Direct) |
View |
2022-06-02 Option Award |
2022-06-06 5:33 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
20,257 | $0 | 39,822 (Direct) |
View |
2022-05-18 Option Award |
2022-05-20 5:36 pm |
N/A 2032-05-18 |
Societal CDMO Inc. | SCTL | Reasons Bryan M. Director |
205,682 | $0 | 273,111 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 8:09 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
15,606 | $0 | 15,606 (Direct) |
View |
2021-04-20 Option Award(A) |
2021-05-17 4:03 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
38,012 | $0 | 38,012 (Direct) |
View |
2021-04-20 Option Award |
2021-04-22 5:58 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
64,935 | $0 | 105,441 (Direct) |
View |
2020-06-06 Exercise |
2020-06-08 5:46 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
7,333 | $0 | 32,709 (Direct) |
View |
2020-06-04 Option Award |
2020-06-08 5:46 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
16,500 | $0 | 32,709 (Direct) |
View |
2020-05-07 Option Award |
2020-05-11 5:05 pm |
N/A 2030-05-07 |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
20,768 | $0 | 52,911 (Direct) |
View |